Richard Arasi, MD
NPI 1447420971 · Specialist · Woodstock, GA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1447420971
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- 32512 (GA)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
18 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
32,185 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 22,499 | $6 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 2,005 | $34 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,086 | $84 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,048 | $119 |
| Destruction of Skin Growth, 1-14 Growths17110 | 967 | $82 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 99 | 73 |
| Hydrocortisone | 80 | 62 |
| Ketoconazole | 59 | 33 |
| Metronidazole | 21 | 16 |
| Fluocinonide | 18 | 16 |
| Mometasone Furoate | 18 | 13 |
| Valacyclovir Hclbrand: Valacyclovir | 14 | — |
| Clindamycin Phosphate | 12 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-03-12
- Last updated
- 2008-03-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.